BI
PCRX icon

Binnacle Investments’s Pacira BioSciences PCRX Stock Holding History

Binnacle Investments’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$206 Buy
+8
New +$196 ﹤0.01% 916
2025
Q2 		– Sell
-8
Closed -$199 – 836
2025
Q1 		$199 Buy
+8
New +$192 ﹤0.01% 769

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Binnacle Investments's PCRX Position: Q3 2025 in Review

Binnacle Investments opened a new position in Pacira BioSciences (PCRX) in Q3 2025: 8 shares worth $206. The stake represents ﹤0.01% of the portfolio and ranks #916 among its holdings. This is a return to the name: Binnacle Investments previously reported a position in PCRX as recently as Q1 2025.

Binnacle Investments first reported a position in PCRX in Q1 2025 and has held it in 2 quarters since. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2025.

  • Binnacle Investments held 8 shares of Pacira BioSciences worth $206 as of Q3 2025.
  • Pacira BioSciences was a new Binnacle Investments position in Q3 2025.
  • Pacira BioSciences made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #916 holding.
  • Binnacle Investments first reported a position in Pacira BioSciences in Q1 2025 and has held it in 2 quarters since.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.